טוען...
Erythropoietin Molecules to Treat Acute Ischemic Stroke: A Translational Dilemna!
IMPORTANCE OF THE FIELD: Since the realization that Erythropoietin (EPO) molecules have “neuroprotective” properties, they have been investigated as treatments for acute ischemic stroke (AIS), but not systematically. The results of the 2009 clinical trial showed that EPO was ineffective as a stroke...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947745/ https://ncbi.nlm.nih.gov/pubmed/20828227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2010.517954 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|